FDA Faces “Conundrum” In Determining Efficacy Of Children’s Cold Products
This article was originally published in The Tan Sheet
Executive Summary
FDA Office of New Drugs Director John Jenkins is uncertain the efficacy of OTC cough/cold ingredients can be accurately assessed in a pediatric population